Gene · 5451
Papers3,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging. | Cancers (Basel) | 2023 | 37568603 | PubTator, text mining | PubMed |
| Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. | Int J Biol Sci | 2023 | 37564197 | PubTator, text mining | PubMed |
| Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. | Front Endocrinol (Lausanne) | 2023 | 37547305 | PubTator, text mining | PubMed |
| BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes. | Mol Cancer | 2023 | 37543582 | PubTator, text mining | PubMed |
| A half century of exploring DNA excision repair in chromatin. | J Biol Chem | 2023 | 37527775 | PubTator, text mining | PubMed |
| USNAP: fast unique dense region detection and its application to lung cancer. | Bioinformatics | 2023 | 37527019 | PubTator, text mining | PubMed |
| Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview. | Proc Jpn Acad Ser B Phys Biol Sci | 2023 | 37518010 | PubTator, text mining | PubMed |
| Role of Macrophage lncRNAs in Mediating Inflammatory Processes in Atherosclerosis and Sepsis. | Biomedicines | 2023 | 37509544 | PubTator, text mining | PubMed |
| GANT-61 induces cell cycle resting and autophagy by down-regulating RNAP III signal pathway and tRNA-Gly-CCC synthesis to combate chondrosarcoma. | Cell Death Dis | 2023 | 37488121 | PubTator, text mining | PubMed |
| First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma. | Mol Cancer Ther | 2023 | 37486983 | PubTator, text mining | PubMed |
| Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer. | BMC Cancer | 2023 | 37474926 | PubTator, text mining | PubMed |
| Computational Construction of Toxicant Signaling Networks. | Chem Res Toxicol | 2023 | 37471124 | PubTator, text mining | PubMed |
| Identification of miRNAs in extracellular vesicles as potential diagnostic markers for pediatric epilepsy and drug-resistant epilepsy via bioinformatics analysis. | Front Pediatr | 2023 | 37469680 | PubTator, text mining | PubMed |
| The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy. | Biomed J | 2023 | 37467968 | PubTator, text mining | PubMed |
| Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features. | Clin Cancer Res | 2023 | 37449970 | PubTator, text mining | PubMed |
| Advances in Low-Lactose/Lactose-Free Dairy Products and Their Production. | Foods | 2023 | 37444291 | PubTator, text mining | PubMed |
| Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma. | J Gastroenterol | 2023 | 37433897 | PubTator, text mining | PubMed |
| Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition. | Acta Pharm Sin B | 2023 | 37425060 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| HSV-1 selectively packs the transcription factor Oct-1 into EVs to facilitate its infection. | Front Microbiol | 2023 | 37396389 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5451/papers?page=9